Trump-era tariffs are reported to be benefiting certain AI stocks, involving Core & Main.
4 reports, 2 independent
Updated Jun 20
Gone quiet
- Reports
- 4
- Developments
- 4
- Repetition
- 0%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Trump-era tariffs are reported to be benefiting certain AI stocks, involving Core & Main.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.Trump's policies regarding tariffs and onshoring are seen as beneficial for AI stocks like nCino.1 source
Tariffs implemented during the Trump era are seen to be benefiting specific AI stocks.1 source
Trump-era tariffs benefit undervalued AI stocks, with a fund highlighting Group 1 Automotive stock.1 source
Jazz Pharmaceuticals is cited as a specific beneficiary of Trump-era tariffs on AI stocks.1 source
Keep exploring
The entities involved
-
Donald Trump
American businessman and politician (born 1946), President of the United States (2017–2021; since 2025)
-
Core & Main
infrastructure (water, wastewater, storm drainage and fire protection) limited partnership company
Nothing else this week.
-
Jazz Pharmaceuticals
Irish tax-registered pharmaceutical corporation
-
Conventum
Swedish company
Nothing else this week.
Coverage
Newest first; wire copies grouped- yahoo.com
- yahoo.com
- Insider MonkeyHere’s Why Group 1 Automotive (GPI) Rose in Q2 Alluvium Asset Management, an asset management company, released its “Conventum – Alluvium Global Fund” second-quarter 2025 investor letter. A copy of t
- Insider MonkeyBofA Raises PT on Jazz Pharmaceuticals (JAZZ) to $225 From $217 Jazz Pharmaceuticals (NASDAQ:JAZZ) is one of the most promising future stocks according to Wall Street analysts. On August 14, BofA rai